108 related articles for article (PubMed ID: 11072870)
1. Nitric oxide inhibits tyrosine hydroxylase of rat median eminence.
Abreu P; Llorente E; Sánchez JJ; González MC
Life Sci; 2000 Sep; 67(16):1941-6. PubMed ID: 11072870
[TBL] [Abstract][Full Text] [Related]
2. Sodium nitroprusside inhibits the tyrosine hydroxylase activity of the median eminence in the rat.
González MC; Llorente E; Abreu P
Neurosci Lett; 1998 Oct; 254(3):133-6. PubMed ID: 10214975
[TBL] [Abstract][Full Text] [Related]
3. Sodium nitroprusside stimulates L-DOPA release from striatal tissue through nitric oxide and cGMP.
Sanchez JJ; Abreu P; Gonzalez MC
Eur J Pharmacol; 2002 Mar; 438(1-2):79-83. PubMed ID: 11906714
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydrobiopterin stimulates L-DOPA release from striatal tissue.
Abreu-González P; González-Hernández T; Afonso-Oramas D; Cruz-Muros I; Barroso-Chinea P; González MC
Eur J Pharmacol; 2006 Jul; 541(1-2):33-7. PubMed ID: 16750826
[TBL] [Abstract][Full Text] [Related]
5. Methylene blue inhibits stimulatory effect of sodium nitroprusside but not of 3-morpholino sydnonimine on prolactin secretion in freely moving male rats.
González MC; Llorente E
Brain Res Bull; 1998 Jun; 46(3):229-31. PubMed ID: 9667816
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
Hwang TL; Wu CC; Teng CM
Br J Pharmacol; 1998 Nov; 125(6):1158-63. PubMed ID: 9863642
[TBL] [Abstract][Full Text] [Related]
7. Self-limiting enhancement by nitric oxide of oxygen free radical-induced endothelial cell injury: evidence against the dual action of NO as hydroxyl radical donor/scavenger.
Az-ma T; Fujii K; Yuge O
Br J Pharmacol; 1996 Oct; 119(3):455-62. PubMed ID: 8894164
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide inhibits neuroendocrine Ca(V)1 L-channel gating via cGMP-dependent protein kinase in cell-attached patches of bovine chromaffin cells.
Carabelli V; D'Ascenzo M; Carbone E; Grassi C
J Physiol; 2002 Jun; 541(Pt 2):351-66. PubMed ID: 12042344
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the mechanisms underlying the relaxation induced by two nitric oxide donors: sodium nitroprusside and a new ruthenium complex.
Bonaventura D; de Lima RG; Vercesi JA; da Silva RS; Bendhack LM
Vascul Pharmacol; 2007 Mar; 46(3):215-22. PubMed ID: 17127100
[TBL] [Abstract][Full Text] [Related]
10. A study on the mechanism by which sodium nitroprusside, a nitric oxide donor, applied to the anteroventral third ventricular region provokes facilitation of vasopressin secretion in conscious rats.
Yamaguchi K; Hama H
Brain Res; 2003 Apr; 968(1):35-43. PubMed ID: 12644262
[TBL] [Abstract][Full Text] [Related]
11. Molecular actions of a Mn(III)Porphyrin superoxide dismutase mimetic and peroxynitrite scavenger: reaction with nitric oxide and direct inhibition of NO synthase and soluble guanylyl cyclase.
Pfeiffer S; Schrammel A; Koesling D; Schmidt K; Mayer B
Mol Pharmacol; 1998 Apr; 53(4):795-800. PubMed ID: 9547373
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide inhibits L-type Ca2+ current in glomus cells of the rabbit carotid body via a cGMP-independent mechanism.
Summers BA; Overholt JL; Prabhakar NR
J Neurophysiol; 1999 Apr; 81(4):1449-57. PubMed ID: 10200181
[TBL] [Abstract][Full Text] [Related]
13. Vascular pharmacology of methylene blue in vitro and in vivo: a comparison with NG-nitro-L-arginine and diphenyleneiodonium.
Wang YX; Cheng X; Pang CC
Br J Pharmacol; 1995 Jan; 114(1):194-202. PubMed ID: 7712018
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro.
Young ME; Radda GK; Leighton B
Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):223-8. PubMed ID: 9078265
[TBL] [Abstract][Full Text] [Related]
15. Iron ions derived from the nitric oxide donor sodium nitroprusside inhibit mineralization.
Huitema LF; van Weeren PR; Barneveld A; van de Lest CH; Helms JB; Vaandrager AB
Eur J Pharmacol; 2006 Aug; 542(1-3):48-53. PubMed ID: 16828741
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of nitric oxide-dependent activation of soluble guanylyl cyclase by the antimalarial drug, artemisinin.
Severina IS; Pyatakova NV; Bussygina OG; Mikhailitsyn FS; Khropov YV
Eur J Pharmacol; 2002 Mar; 438(1-2):69-73. PubMed ID: 11906712
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide- and nitric oxide donors-induced relaxation and its modulation by oxidative stress in piglet pulmonary arteries.
López-López JG; Pérez-Vizcaíno F; Cogolludo AL; Ibarra M; Zaragozá-Arnáez F; Tamargo J
Br J Pharmacol; 2001 Jul; 133(5):615-24. PubMed ID: 11429384
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT).
Bryan-Lluka LJ; Papacostas MH; Paczkowski FA; Wanstall JC
Br J Pharmacol; 2004 Sep; 143(1):63-70. PubMed ID: 15302679
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of the effects of three guanylyl cyclase inhibitors on the L-type Ca2+ and muscarinic K+ currents in frog cardiac myocytes.
Abi-Gerges N; Hove-Madsen L; Fischmeister R; Méry PF
Br J Pharmacol; 1997 Aug; 121(7):1369-77. PubMed ID: 9257916
[TBL] [Abstract][Full Text] [Related]
20. [The effect of nitric oxide on the contractile activity of skinned preparations of the smooth muscles of the rat portal vein].
Sahach VF; Andrukhov OIa
Fiziol Zh (1994); 2000; 46(1):3-9. PubMed ID: 10758824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
